{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T15:40:20Z","timestamp":1791819620609,"version":"4.3.4"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.bone.2024.117130","type":"journal-article","created":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T03:47:02Z","timestamp":1716436022000},"page":"117130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Association between primary hyperparathyroidism and cardiovascular outcomes: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"185","author":[{"given":"Siang-Ke","family":"Kong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Chieh","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Lin","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Cheng","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Nan","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Chuan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Hsuan","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bone.2024.117130_bb0005","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1210\/jc.2012-4022","article-title":"Incidence and prevalence of primary hyperparathyroidism in a racially mixed population","volume":"98","author":"Yeh","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"20","key":"10.1016\/j.bone.2024.117130_bb0010","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1016\/j.ehj.2004.07.010","article-title":"Primary hyperparathyroidism and heart disease--a review","volume":"25","author":"Andersson","year":"2004","journal-title":"Eur. Heart J."},{"issue":"11","key":"10.1016\/j.bone.2024.117130_bb0015","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1002\/jbmr.4677","article-title":"Evaluation and Management of Primary Hyperparathyroidism: summary statement and guidelines from the fifth international workshop","volume":"37","author":"Bilezikian","year":"2022","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.bone.2024.117130_bb0020","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12872-019-1093-4","article-title":"Parathyroidectomy improves cardiovascular risk factors in normocalcemic and hypercalcemic primary hyperparathyroidism","volume":"19","author":"Beysel","year":"2019","journal-title":"BMC Cardiovasc. Disord."},{"issue":"2","key":"10.1016\/j.bone.2024.117130_bb0025","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1507\/endocrj.EJ15-0392","article-title":"Patients with normocalcemic primary hyperparathyroidism may have similar metabolic profile as hypercalcemic patients","volume":"63","author":"Yener Ozturk","year":"2016","journal-title":"Endocr. J."},{"issue":"21","key":"10.1016\/j.bone.2024.117130_bb0030","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1161\/CIRCULATIONAHA.108.808733","article-title":"Plasma parathyroid hormone and the risk of cardiovascular mortality in the community","volume":"119","author":"Hagstr\u00f6m","year":"2009","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.bone.2024.117130_bb0035","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1093\/eurjhf\/hfq134","article-title":"Plasma parathyroid hormone and risk of congestive heart failure in the community","volume":"12","author":"Hagstr\u00f6m","year":"2010","journal-title":"Eur. J. Heart Fail."},{"issue":"5","key":"10.1016\/j.bone.2024.117130_bb0040","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1161\/CIRCHEARTFAILURE.114.001272","article-title":"Elevated parathyroid hormone, but not vitamin D deficiency, is associated with increased risk of heart failure in older men with and without cardiovascular disease","volume":"7","author":"Wannamethee","year":"2014","journal-title":"Circ. Heart Fail."},{"issue":"5","key":"10.1016\/j.bone.2024.117130_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2013.02.014","article-title":"Parathyroid hormone and cardiovascular disease events: a systematic review and meta-analysis of prospective studies","volume":"165","author":"van Ballegooijen","year":"2013","journal-title":"Am Heart J."},{"issue":"6","key":"10.1016\/j.bone.2024.117130_bb0050","doi-asserted-by":"crossref","first-page":"R297","DOI":"10.1530\/EJE-17-0485","article-title":"Cardiovascular manifestations of primary hyperparathyroidism: a narrative review","volume":"177","author":"Pepe","year":"2017","journal-title":"Eur. J. Endocrinol."},{"issue":"12","key":"10.1016\/j.bone.2024.117130_bb0055","doi-asserted-by":"crossref","first-page":"4399","DOI":"10.1210\/jc.2015-3202","article-title":"Effect of parathyroidectomy upon left ventricular mass in primary hyperparathyroidism: a meta-analysis","volume":"100","author":"McMahon","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"43","key":"10.1016\/j.bone.2024.117130_bb0060","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000007255","article-title":"Echocardiogram changes following parathyroidectomy for primary hyperparathyroidism: a systematic review and meta-analysis","volume":"96","author":"Best","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"8","key":"10.1016\/j.bone.2024.117130_bb0065","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1210\/jc.2018-02456","article-title":"Effect of parathyroidectomy on cardiovascular risk factors in primary hyperparathyroidism: a randomized clinical trial","volume":"104","author":"Ejlsmark-Svensson","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2024.117130_bb0070","series-title":"Glucose Metabolic Disorder in Primary Hyperparathyroidism: A Systematic Review and Meta-analysis","author":"Sun","year":"2019"},{"key":"10.1016\/j.bone.2024.117130_bb0075","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.bone.2024.117130_bb0080","unstructured":"Higgins J, Morgan R, Rooney A, Taylor K, Thayer K, Silva R, et al.;Pages https:\/\/www.riskofbias.info\/welcome\/robins-e-tool#h.trqnh6qozyhl."},{"key":"10.1016\/j.bone.2024.117130_bb0085","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.bone.2024.117130_bb0090","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.bone.2024.117130_bb0095","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0002-9343(97)00270-2","article-title":"Survival after the diagnosis of hyperparathyroidism: a population-based study","volume":"104","author":"Wermers","year":"1998","journal-title":"Am. J. Med."},{"key":"10.1016\/j.bone.2024.117130_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2021.116099","article-title":"Survival in primary hyperparathyroidism over five decades (1965-2010) a population-based retrospective study","volume":"152","author":"Wermers","year":"2021","journal-title":"Bone"},{"issue":"2","key":"10.1016\/j.bone.2024.117130_bb0105","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s00268-002-6541-z","article-title":"Cardiovascular events before and after surgery for primary hyperparathyroidism","volume":"27","author":"Vestergaard","year":"2003","journal-title":"World J. Surg."},{"issue":"7414","key":"10.1016\/j.bone.2024.117130_bb0110","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/bmj.327.7414.530","article-title":"Cohort study on effects of parathyroid surgery on multiple outcomes in primary hyperparathyroidism","volume":"327","author":"Vestergaard","year":"2003","journal-title":"Bmj"},{"issue":"1","key":"10.1016\/j.bone.2024.117130_bb0115","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1365-2265.2009.03766.x","article-title":"Increased mortality and morbidity in mild primary hyperparathyroid patients. The parathyroid epidemiology and audit research study (PEARS)","volume":"73","author":"Yu","year":"2010","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"2","key":"10.1016\/j.bone.2024.117130_bb0120","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1365-2265.2010.03958.x","article-title":"A record linkage study of outcomes in patients with mild primary hyperparathyroidism: the parathyroid epidemiology and audit research study (PEARS)","volume":"75","author":"Yu","year":"2011","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"1","key":"10.1016\/j.bone.2024.117130_bb0125","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/cen.12206","article-title":"What predicts adverse outcomes in untreated primary hyperparathyroidism? The parathyroid epidemiology and audit research study (PEARS)","volume":"79","author":"Yu","year":"2013","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"4","key":"10.1016\/j.bone.2024.117130_bb0130","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1046\/j.1365-2362.1998.00289.x","article-title":"Increased risk of death from primary hyperparathyroidism--an update","volume":"28","author":"Hedb\u00e4ck","year":"1998","journal-title":"Eur. J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.bone.2024.117130_bb0135","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.surg.2004.05.044","article-title":"Mortality in sporadic primary hyperparathyroidism: nationwide cohort study of multiple parathyroid gland disease","volume":"136","author":"Nilsson","year":"2004","journal-title":"Surgery"},{"issue":"1","key":"10.1016\/j.bone.2024.117130_bb0140","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s00268-003-7046-0","article-title":"Increased mortality in patients hospitalized with primary hyperparathyroidism during the period 1977-1993 in Denmark","volume":"28","author":"\u00d8gard","year":"2004","journal-title":"World J. Surg."},{"issue":"2","key":"10.1016\/j.bone.2024.117130_bb0145","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1530\/EJE-08-0523","article-title":"Postoperative mortality in parathyroid surgery in Sweden during five decades: improved outcome despite older patients","volume":"160","author":"Norenstedt","year":"2009","journal-title":"Eur. J. Endocrinol."},{"issue":"4","key":"10.1016\/j.bone.2024.117130_bb0150","doi-asserted-by":"crossref","first-page":"335","DOI":"10.4158\/EP-2018-0407","article-title":"Increased mortality in patients with primary hyperparathyroidism: does surgery make a difference?","volume":"25","author":"Collier","year":"2019","journal-title":"Endocr. Pract."},{"issue":"7","key":"10.1016\/j.bone.2024.117130_bb0155","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1093\/bjs\/znab017","article-title":"Mortality after surgery for primary hyperparathyroidism: results from a nationwide cohort","volume":"108","author":"Nilsson","year":"2021","journal-title":"Br. J. Surg."},{"issue":"2","key":"10.1016\/j.bone.2024.117130_bb0160","doi-asserted-by":"crossref","first-page":"e302","DOI":"10.1097\/SLA.0000000000005691","article-title":"Adverse cardiovascular outcomes among older adults with primary hyperparathyroidism treated with parathyroidectomy vs. non-operative management","volume":"278","author":"Seib","year":"2022","journal-title":"Ann. Surg."},{"issue":"6","key":"10.1016\/j.bone.2024.117130_bb0165","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.15396","article-title":"Analysis of comorbidities, clinical outcomes, and parathyroidectomy in adults with primary hyperparathyroidism","volume":"5","author":"Axelsson","year":"2022","journal-title":"JAMA Netw. Open"},{"issue":"6","key":"10.1016\/j.bone.2024.117130_bb0170","doi-asserted-by":"crossref","first-page":"812","DOI":"10.7326\/M21-4416","article-title":"Mortality and morbidity in mild primary hyperparathyroidism: results from a 10-year prospective randomized controlled trial of parathyroidectomy versus observation","volume":"175","author":"Pretorius","year":"2022","journal-title":"Ann. Intern. Med."},{"issue":"6","key":"10.1016\/j.bone.2024.117130_bb0175","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.15396","article-title":"Analysis of comorbidities, clinical outcomes, and parathyroidectomy in adults with primary hyperparathyroidism","volume":"5","author":"Axelsson","year":"2022","journal-title":"JAMA Netw. Open"},{"issue":"9","key":"10.1016\/j.bone.2024.117130_bb0180","doi-asserted-by":"crossref","first-page":"3692","DOI":"10.1210\/jc.2018-02483","article-title":"Predictors of nephrolithiasis, osteoporosis, and mortality in primary hyperparathyroidism","volume":"104","author":"Reid","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.bone.2024.117130_bb0185","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0008-6363(97)00194-6","article-title":"Cardiovascular actions of parathyroid hormone and parathyroid hormone-related peptide","volume":"37","author":"Schl\u00fcter","year":"1998","journal-title":"Cardiovasc. Res."},{"issue":"6","key":"10.1016\/j.bone.2024.117130_bb0190","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/cen.12666","article-title":"Impaired endothelial function in patients with mild primary hyperparathyroidism improves after parathyroidectomy","volume":"83","author":"Tuna","year":"2015","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"11","key":"10.1016\/j.bone.2024.117130_bb0195","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/j.1365-2362.2008.02033.x","article-title":"Parathyroid hormone stimulates the endothelial expression of vascular endothelial growth factor","volume":"38","author":"Rashid","year":"2008","journal-title":"Eur. J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.bone.2024.117130_bb0200","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1210\/jc.2004-1400","article-title":"Arterial stiffness in mild primary hyperparathyroidism","volume":"90","author":"Rubin","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.bone.2024.117130_bb0205","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.surg.2015.07.037","article-title":"A pilot study investigating the effect of parathyroidectomy on arterial stiffness and coronary artery calcification in patients with primary hyperparathyroidism","volume":"159","author":"Dural","year":"2016","journal-title":"Surgery"},{"issue":"1","key":"10.1016\/j.bone.2024.117130_bb0210","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1210\/jc.2011-2107","article-title":"Aortic valve calcification in mild primary hyperparathyroidism","volume":"97","author":"Iwata","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.bone.2024.117130_bb0215","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s40618-021-01645-x","article-title":"Cardiac structural and functional abnormalities in primary hyperparathyroidism","volume":"45","author":"Purra","year":"2022","journal-title":"J. Endocrinol. Invest."},{"issue":"4","key":"10.1016\/j.bone.2024.117130_bb0220","doi-asserted-by":"crossref","first-page":"F1215","DOI":"10.1152\/ajprenal.00406.2006","article-title":"Parathyroid hormone stimulates endothelial expression of atherosclerotic parameters through protein kinase pathways","volume":"292","author":"Rashid","year":"2007","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"1","key":"10.1016\/j.bone.2024.117130_bb0225","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1365-2265.1994.tb02442.x","article-title":"Impaired glucose tolerance and insulin insensitivity in primary hyperparathyroidism","volume":"40","author":"Kumar","year":"1994","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"11","key":"10.1016\/j.bone.2024.117130_bb0230","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1053\/meta.2000.17708","article-title":"Insulin sensitivity is inversely correlated with plasma intact parathyroid hormone level","volume":"49","author":"Chiu","year":"2000","journal-title":"Metabolism"},{"issue":"4","key":"10.1016\/j.bone.2024.117130_bb0235","first-page":"2045","article-title":"Cardiovascular responsiveness to parathyroid hormone (PTH) and PTH-related protein in genetic hypertension","volume":"130","author":"DiPette","year":"1992","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.bone.2024.117130_bb0240","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.metabol.2013.08.016","article-title":"Aldosterone and parathyroid hormone interactions as mediators of metabolic and cardiovascular disease","volume":"63","author":"Tomaschitz","year":"2014","journal-title":"Metabolism"},{"issue":"6","key":"10.1016\/j.bone.2024.117130_bb0245","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.surg.2009.09.041","article-title":"Serum aldosterone is correlated positively to parathyroid hormone (PTH) levels in patients with primary hyperparathyroidism","volume":"146","author":"Brunaud","year":"2009","journal-title":"Surgery"},{"issue":"9","key":"10.1016\/j.bone.2024.117130_bb0250","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1097\/HJH.0000000000001004","article-title":"Parathyroid hormone, aldosterone-to-renin ratio and fibroblast growth factor-23 as determinants of nocturnal blood pressure in primary hyperparathyroidism: the eplerenone in primary hyperparathyroidism trial","volume":"34","author":"Verheyen","year":"2016","journal-title":"J. Hypertens."},{"issue":"1","key":"10.1016\/j.bone.2024.117130_bb0255","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.metabol.2006.08.019","article-title":"Circulating leptin and adiponectin levels in patients with primary hyperparathyroidism","volume":"56","author":"Delfini","year":"2007","journal-title":"Metabolism"},{"issue":"7","key":"10.1016\/j.bone.2024.117130_bb0260","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1515\/cclm-2016-1159","article-title":"Low-grade inflammation and tryptophan-kynurenine pathway activation are associated with adverse cardiac remodeling in primary hyperparathyroidism: the EPATH trial","volume":"55","author":"Verheyen","year":"2017","journal-title":"Clin. Chem. Lab. Med."},{"issue":"1\u20133","key":"10.1016\/j.bone.2024.117130_bb0265","first-page":"63","article-title":"Effect of parathyroid hormone on left ventricular diastolic function in patients with primary hyperparathyroidism","volume":"21","author":"Ohara","year":"1995","journal-title":"Miner. Electrolyte Metab."},{"issue":"7","key":"10.1016\/j.bone.2024.117130_bb0270","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1007\/s00268-005-7740-1","article-title":"Myocardial perfusion defects and the left ventricular ejection fraction disclosed by scintigraphy in patients with primary hyperparathyroidism","volume":"29","author":"Ogard","year":"2005","journal-title":"World J. Surg."},{"issue":"4","key":"10.1016\/j.bone.2024.117130_bb0275","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1161\/CIRCULATIONAHA.107.706127","article-title":"Vitamin D deficiency and risk of cardiovascular disease","volume":"117","author":"Wang","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.bone.2024.117130_bb0280","doi-asserted-by":"crossref","first-page":"46","DOI":"10.5005\/jp-journals-10002-1209","article-title":"Assessment of cardiovascular system abnormalities in patients with advanced primary hyperparathyroidism by detailed echocardiographic analysis: a prospective study","volume":"9","author":"Mishra","year":"2017","journal-title":"World Journal of Endocrine Surgery."},{"issue":"5","key":"10.1016\/j.bone.2024.117130_bb0285","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1530\/EJE-09-1067","article-title":"Cardiovascular risk factors and arterial rigidity are similar in asymptomatic normocalcemic and hypercalcemic primary hyperparathyroidism","volume":"162","author":"Tordjman","year":"2010","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.bone.2024.117130_bb0290","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/408295","article-title":"Arterial hypertension, metabolic syndrome and subclinical cardiovascular organ damage in patients with asymptomatic primary hyperparathyroidism before and after parathyroidectomy: preliminary results","volume":"2012","author":"Luigi","year":"2012","journal-title":"Int. J. Endocrinol."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328224001194?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328224001194?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T01:19:17Z","timestamp":1718587157000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328224001194"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":58,"alternative-id":["S8756328224001194"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2024.117130","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between primary hyperparathyroidism and cardiovascular outcomes: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2024.117130","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117130"}}